Point72 Asia (Singapore) Pte. Ltd. Aquestive Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 40,957 shares of AQST stock, worth $99,115. This represents 0.05% of its overall portfolio holdings.
Number of Shares
40,957Holding current value
$99,115% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$23.7 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$13.4 Million2.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$7.85 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.37 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$3.74 Million0.06% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $129M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...